Table 46Thromboembolic events: epoetin or darbepoetin versus control—current report, current with trials excluded but in 2006 review, and 2006 review

ComparisonTrialsEpoetin or Darbepoetin NControl NRR (95% CI)I2
Current376,4486,0061.51 (1.30 to 1.74)0%
Current & Excluded446,9166,3101.53 (1.33 to 1.77)0%
2006 review313,5102,8961.68 (1.36 to 2.08)0%

CI = confidence interval; RR = relative risk

From: Results

Cover of Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment
Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment: Comparative Effectiveness Update [Internet].
Comparative Effectiveness Reviews, No. 113.
Grant MD, Piper M, Bohlius J, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.